Reduced Neuroendocrine and Symptomatic Responses to Subsequent Hypoglycemia After 1 Episode of Hypoglycemia in Nondiabetic Humans

To test the hypothesis that hypoglycemia itself causes reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia, we measured those responses during clamped hypoglycemia (2.8 mM) on consecutive mornings on two occasions, with interval afternoon (1400–1600) hypoglycemia (3 mM) on one occasion and interval afternoon euglycemia (5 mM) on the other, in nine nondiabetic humans. None of the measured responses were reduced by interval euglycemia. In contrast, plasma epinephrine (P < 0.005), glucagon (P < 0.005), pancreatic polypeptide (P < 0.01), cortisol (P < 0.02), and total (P < 0.001), neurogenic (P < 0.001) and neuroglycopenic (P < 0.05) symptom responses to morning hypoglycemia were reduced after interval afternoon hypoglycemia. Thus, a single episode of hypoglycemia caused a generalized reduction of the neuroendocrine and symptomatic responses to subsequent hypoglycemia, a finding that may be important to the pathogenesis of iatrogenic hypoglycemia in insulin-dependent diabetes mellitus.

[1]  P. Cryer,et al.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. , 1987, The Journal of clinical investigation.

[2]  K.,et al.  Experimental validation of measurements of glucose turnover in nonsteady state. , 1978, The American journal of physiology.

[3]  U. Adamson,et al.  Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus. , 1988, Acta endocrinologica.

[4]  D. Ewing,et al.  Unawareness of Hypoglycaemia in Insulin‐treated Diabetic Patients: Prevalence and Relationship to Autonomic Neuropathy , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[5]  P. Lacy,et al.  Regional Pancreatic Concentration and In-vitro Secretion of Canine Pancreatic Polypeptide, Insulin, and Glucagon , 1978, Diabetes.

[6]  P. Cryer Does central nervous system adaptation to antecedent glycemia occur in patients with insulin-dependent diabetes mellitus? , 1985, Annals of internal medicine.

[7]  L. Travis Hypoglycemia in insulin-dependent diabetes mellitus. , 1989, The Journal of pediatrics.

[8]  G. W. Thorn,et al.  Plasma epinephrine and norepinephrine levels during insulin-induced hypoglycemia in man. , 1961, The Journal of clinical endocrinology and metabolism.

[9]  U. Smith,et al.  Combined Effect of Growth Hormone and Cortisol on Late Posthypoglycemic Insulin Resistance in Humans , 1989, Diabetes.

[10]  I. Macdonald,et al.  INFLUENCE OF SYMPATHETIC NERVOUS SYSTEM ON HYPOGLYCAEMIC WARNING SYMPTOMS , 1987, The Lancet.

[11]  W. Tamborlane,et al.  Effect of Intensive Insulin Therapy on Glycemic Thresholds for Counterregulatory Hormone Release , 1988, Diabetes.

[12]  P. Cryer,et al.  Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. , 1988, The New England journal of medicine.